1 study found for:    23388004 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396 topical cream;   Drug: Paromomycin Alone topical cream;   Drug: Vehicle placebo cream

Indicates status has not been verified in more than two years